T1	intervention 113 124	Abemaciclib
T2	intervention-participants 628 631	900
T3	control-participants 667 670	384
T4	control 671 689	comparator therapy
T5	outcome 1125 1142	Physical function
T6	outcome 1348 1351	PFS
T8	outcome 1526 1543	intermediate/high
T7	outcome 1468 1489	low physical function
